Updated 21 October 2026.
An AI scribe helps create an account of a clinical encounter. Clinical decision support helps a professional consider what that information means or what to do next. The distinction is increasingly important as both functions appear inside the same products, but it should not be mistaken for a simple division between harmless administration and risky medicine.
A misleading note can affect subsequent care. An evidence answer can be useful without being authorised to make a treatment decision. The correct comparison begins with the function, the intended use and the consequences of error, rather than assuming that the label "scribe" settles the risk.
Why documentation and decision support are converging
A consultation generates questions as well as a record. Once an assistant can organise the encounter, it is commercially attractive to let the clinician ask about relevant guidance without moving to another application. Shared context may reduce repeated typing and make the next feature easier to discover.
Tandem's Clinical Decision Support product illustrates this movement towards evidence questions alongside clinical workflow. Its July release notes also describe standalone chats and documents, so the competitive overlap with reference platforms is not restricted to recorded consultations.
The strategic appeal is understandable. A supplier that already serves a clinician during documentation has an opportunity to provide another useful function at the same moment. The unresolved question is whether that proximity produces better decisions, lower effort or merely more activity inside the application.
The outputs require different tests
Documentation should be assessed against the encounter and the intended record. Did it preserve important positive and negative findings? Did it attribute statements correctly? Did it distinguish a proposed action from an action already completed? Was anything invented, omitted or transformed in a clinically consequential way?
Decision support requires additional questions. Did the system identify the relevant clinical issue? Are the cited sources applicable and current? Does the answer respect the patient's characteristics and the jurisdiction? Does it acknowledge when the supplied information is insufficient to support a recommendation?
A product could perform well on one set of tests and poorly on another. Procurement should not transfer confidence from fluent note generation to diagnostic or therapeutic suggestions without evaluating the new function. The reverse is also true: a strong evidence search does not establish reliable capture of a difficult conversation.
Regulatory classification is not settled by the interface
The MHRA's guidance on ambient voice technology-enabled products distinguishes functions according to their purpose and characteristics. A product that documents information for professional review raises different qualification questions from one that introduces new medical recommendations. Marketing, design and actual functionality can all be relevant to intended purpose.
The EU framework must be considered separately. MDCG software guidance explains software qualification and classification, including the role of Rule 11. A simplified table stating that every scribe is Class I and every clinical assistant is Class IIa would conceal important differences between products and jurisdictions.
This is particularly relevant after the UK CE-recognition announcement. Recognition can provide a route for qualifying EU-assessed devices into Great Britain, but it does not merge the two classification systems or create a blanket exemption for functions described as administrative.
Could decision support become the more valuable function?
Possibly, but it depends on what value is being measured. Documentation may offer a relatively visible time-saving proposition. Decision support may be valuable because it helps the clinician find relevant evidence, recognise uncertainty or avoid unnecessary searching. These benefits require different evidence and may accrue to different stakeholders.
A hospital purchasing software may prioritise reliable documentation, record completion and deployment costs. An individual clinician may place greater value on access to an independent reference or a tool that helps explain a difficult concept. A single ranking of "most valuable" obscures those differences.
There is also a commercial tension. A workflow platform might bundle evidence access at a low incremental price to strengthen retention. An independent reference provider must then demonstrate why its depth, navigation, provenance or educational experience justifies separate attention. That is a strategic possibility, not proof that the market has already reached that outcome.
Context is useful, but it is not always complete
An assistant may have access to the current transcript without having the entire relevant history. A patient may not mention a medicine, previous investigation or important preference during that conversation. The interface should make the available context understandable rather than encourage the impression that it knows everything in the record.
More context can also include irrelevant, outdated or contradictory information. The challenge is not merely acquiring additional text. It is deciding what information matters, where it came from and whether it should influence the answer.
A useful assessment therefore includes deliberately incomplete cases. The question is whether the tool asks for missing information, limits its conclusion or proceeds with unjustified confidence. This should be tested for the actual function and configuration being purchased, not assumed from the brand's general performance claims.
Personalisation should not be confused with better clinical reasoning
Tandem's Adaptive Notes announcement on 21 October describes adaptation to clinicians' editing preferences. That is relevant to documentation workload and user experience. It should not be described as evidence that the system autonomously learns new medical knowledge or improves its clinical reasoning from every consultation.
The distinction matters in evaluation. A note that sounds more like the clinician may require fewer stylistic edits while still needing the same factual scrutiny. A familiar writing style can make a product more pleasant to use without establishing anything about the accuracy of a separate evidence answer.
Organisations should therefore measure stylistic convenience and clinical fidelity separately. The former is a legitimate product benefit; the latter remains essential to the use being assessed.
Learning remains a separate source of value
This article is published by iatroX, whose reference, Tutor and simulations serve a combination of information access and active learning. The educational opportunity is not simply to display another answer, but to create space for the clinician to reason, attempt and review.
An integrated evidence assistant may be the most convenient tool for a particular consultation. A dedicated learning environment may be better suited to revisiting the underlying principle after the encounter. Neither proposition requires claiming that documentation automation is inherently harmful or that every independent tool produces better learning.
The next phase of competition is therefore broader than a battle to attach a chat box to a scribe. Suppliers must show which tasks they improve, how those improvements are evaluated and whether the combined experience preserves appropriate clinical judgement. Documentation, evidence and learning can reinforce one another, but they should not be treated as interchangeable products.
Frequently asked questions
Is an AI scribe automatically a low-risk administrative tool?
No. The function, intended purpose and consequences of error matter. Documentation can influence later care, and the regulatory assessment depends on the product and jurisdiction rather than the name alone.
Does consultation context make decision support more accurate?
It may improve relevance, but context can also be incomplete or misleading. The benefit needs evaluation against the intended task, including cases where important information is absent.
Can a clinician use a scribe and a separate learning platform?
Yes. Documentation support and active learning serve different needs. Any clinical use should remain within the organisation's governance arrangements and the products' intended purposes.
Connect reference with deliberate practice
Explore iatroX's clinical learning tools to move beyond finding an answer towards practising the reasoning behind it.